Connect your AI

BBNX BBNX Change in Other Liabilities

Change in Other Liabilities at other companies

Tandem Diabetes CareTNDM

$762K+18.3%

Other financials

Income statement

Revenue$27.6M+56.6%

Gross profit$16.4M+83.2%

Operating income-$24.3M-30.2%

Net income-$21.9M+23.6%

EPS (diluted)-$0.49+47.3%

Balance sheet

Cash & equivalents$30.2M-28.9%

Total debt$6.9M-0.9%

Total equity$271.2M-13.5%

Total assets$304.4M-9.9%

Cash flow

Operating cash flow-$23.8M-19.3%

CapEx$1.4M+314%

Free cash flow-$25.2M-24.1%

Valuation

Market cap$708.98M-8.6%

Enterprise value$685.68M—

P/S6.4×—

Profitability

Gross margin57.2%+3.2pp

Operating margin-70.1%-6.4pp

Net margin-60.3%-17.4pp

FCF margin-55.4%-14.3pp

Returns & leverage

Return on equity-22.7%—

Debt / equity0×0.0×

Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BBNX's change in other liabilities?: BBNX (BBNX) reported change in other liabilities of $11K in Q1 2026.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.